solar equipment for the solar energy business of the company. Such a transaction happened only in year 2017, no more in year 2018. Selling and administration expenses Selling expenses increased Baht 0 . 3
increased ,while the Social security revenue of subsidiaries decreased. Payment system of Social security office is uncertain therefore in Q1/2019 subsidiaries did not receive revenue of chromic disease. 2
held on 24 December 2018 has considered carefully and thoroughly. The Board of Director’s meeting has considered relevant factors prior to the approval of entering into the transaction and rationale
Microsoft Word - NMG - SET Disclosure on BoD resolutions (NML) (EN) 28 August 2018 Subject: Entering into the Transaction of Disposal of All Investments in NML Co., Ltd., a Subsidiary of the Company
Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
Transaction Asset. The Company will submit the opinion of the Independent Financial Advisor to the shareholders for consideration together with the invitation to the Extraordinary General Meeting of
Transaction Asset. The Company will submit the opinion of the Independent Financial Advisor to the shareholders for consideration together with the invitation to the Extraordinary General Meeting of
1 25 May 2020 Subject: Notification on Resolution of the Board of Directors’ Meeting No. 5/2020, Change of Directors and Directors’ Power, Entering into Connected Transaction, Entering into
Report on Changes of Securities and Derivatives Holding in Reported by Position Reference No. Name of securities/derivatives holder Type of securities and derivatives Transaction Date No. of
Report on Changes of Securities and Derivatives Holding in Reported by Position Reference No. Name of securities/derivatives holder Type of securities and derivatives Transaction Date No. of